BSE Live
Jan 27, 09:16Prev. Close
3926.95
Open Price
3933.45
Bid Price (Qty.)
3937.10 (12)
Offer Price (Qty.)
3945.95 (1)
NSE Live
Jan 27, 09:16Prev. Close
3932.20
Open Price
3968.00
Bid Price (Qty.)
3941.40 (8)
Offer Price (Qty.)
3943.20 (47)
| Balance Sheet of Torrent Pharmaceuticals (in Rs. Cr.) | Mar 10 | Mar 09 | Mar 08 | Mar 07 | Mar 06 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 42.31 | 42.31 | 42.31 | 42.31 | 42.31 | |
| Total Share Capital | 42.31 | 42.31 | 42.31 | 42.31 | 42.31 | |
| Reserves and Surplus | 838.54 | 690.37 | 542.94 | 422.07 | 340.21 | |
| Total Reserves and Surplus | 838.54 | 690.37 | 542.94 | 422.07 | 340.21 | |
| Total Shareholders Funds | 880.85 | 732.68 | 585.25 | 464.38 | 382.52 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 396.91 | 407.06 | 303.17 | 260.90 | 244.09 | |
| Deferred Tax Liabilities [Net] | 75.26 | 78.72 | 76.18 | 69.48 | 57.57 | |
| Other Long Term Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long Term Provisions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Non-Current Liabilities | 472.17 | 485.78 | 379.36 | 330.38 | 301.66 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 125.49 | 75.00 | 38.43 | 18.08 | 0.00 | |
| Trade Payables | 261.66 | 221.80 | 166.56 | 133.95 | 122.62 | |
| Other Current Liabilities | 38.26 | 52.65 | 23.17 | 7.48 | 6.38 | |
| Short Term Provisions | 82.55 | 57.54 | 49.90 | 15.42 | 31.90 | |
| Total Current Liabilities | 507.97 | 406.99 | 278.06 | 174.93 | 160.90 | |
| Total Capital And Liabilities | 1,860.98 | 1,625.46 | 1,242.67 | 969.69 | 845.08 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 512.64 | 477.02 | 440.03 | 395.73 | 344.50 | |
| Intangible Assets | 12.99 | 10.21 | 7.48 | 7.39 | 7.07 | |
| Capital Work-In-Progress | 105.38 | 45.73 | 78.60 | 39.78 | 33.93 | |
| Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Fixed Assets | 631.01 | 532.96 | 526.11 | 442.90 | 385.50 | |
| Non-Current Investments | 231.48 | 244.96 | 158.05 | 94.97 | 73.77 | |
| Deferred Tax Assets [Net] | 13.19 | 10.39 | 6.71 | 6.18 | 2.08 | |
| Long Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Non-Current Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Non-Current Assets | 875.67 | 788.30 | 690.87 | 544.05 | 461.36 | |
| CURRENT ASSETS | ||||||
| Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Inventories | 227.88 | 191.84 | 166.53 | 185.89 | 163.36 | |
| Trade Receivables | 259.78 | 240.81 | 198.48 | 165.61 | 111.10 | |
| Cash And Cash Equivalents | 346.79 | 183.31 | 97.67 | 10.25 | 60.96 | |
| Short Term Loans And Advances | 150.86 | 221.08 | 89.11 | 63.89 | 47.89 | |
| OtherCurrentAssets | 0.00 | 0.11 | 0.01 | 0.01 | 0.41 | |
| Total Current Assets | 985.31 | 837.15 | 551.80 | 425.64 | 383.72 | |
| Total Assets | 1,860.98 | 1,625.46 | 1,242.67 | 969.69 | 845.08 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 72.91 | 35.80 | 44.03 | 31.86 | 40.82 | |
| CIF VALUE OF IMPORTS | ||||||
| Raw Materials | 173.38 | 151.07 | 143.22 | 109.44 | 114.77 | |
| Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Goods | 22.53 | 9.12 | 15.16 | 10.09 | 11.44 | |
| EXPENDITURE IN FOREIGN EXCHANGE | ||||||
| Expenditure In Foreign Currency | 72.58 | 77.94 | 59.17 | 65.18 | 45.56 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
| Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
| EARNINGS IN FOREIGN EXCHANGE | ||||||
| FOB Value Of Goods | 442.00 | 330.17 | 222.18 | 164.56 | 134.42 | |
| Other Earnings | 22.24 | 19.06 | 10.57 | 9.11 | 3.82 | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | 35.49 | 35.49 | 35.49 | 35.49 | 35.49 | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Non-Current Investments Unquoted Book Value | 231.48 | 244.96 | 158.05 | 94.97 | 73.77 | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Current Investments Unquoted Book Value | -- | -- | -- | -- | -- |
27.01.2026
09.01.2026
05.12.2025
14.11.2025
Torrent Pharma Consolidated September 2025 Net Sales at Rs 3,302.00 crore, up 14.3% Y-o-Y
14.11.2025
Torrent Pharma Consolidated September 2025 Net Sales at Rs 3,302.00 crore, up 14.3% Y-o-Y
12.11.2025
Torrent Pharma Standalone September 2025 Net Sales at Rs 2,762.00 crore, up 13.48% Y-o-Y
29.07.2025
Torrent Pharma Consolidated June 2025 Net Sales at Rs 3,178.00 crore, up 11.16% Y-o-Y
29.07.2025
Torrent Pharma Standalone June 2025 Net Sales at Rs 2,616.00 crore, up 7.3% Y-o-Y
12.07.2023
Torrent Pharma Q1 PAT may dip 9.7% YoY to Rs 319.7 cr: Nirmal Bang
17.01.2023
Torrent Pharma Q3 PAT seen up 28.9% YoY to Rs 3,211 cr: Nirmal Bang
13.07.2022
Torrent Pharma Q1 PAT seen up 2.8% YoY to Rs 339.1 cr: ICICI Direct
08.07.2022
Torrent Pharmaceuticals Q1 PAT seen up 1.4% YoY to Rs 334.5 cr: Prabhudas Lilladher
24.07.2019
Torrent Pharma shares jump 6% as brokerages remain bullish after Q1 show
25.08.2018
Pharma Q1 review: Brokerages say performance a mixed bag, but are upbeat on domestic biz
22.01.2014
14.01.2012